Craneware Plc (GB:CRW)
LSE:CRW
Want to see GB:CRW full AI Analyst Report?
CRW Stock Chart & Stats
2230.00 p
-80.00 p(-3.72%)
At close: 4:00 PM EST
2230.00 p
-80.00 p(-3.72%)
Day’s Range― - ―
52-Week Range1,272.34 p - 2,644.00 p
Previous CloseN/A
Volume2.39K
Average Volume (3M)71.71K
Market Cap
£478.34M
Enterprise Value657.68M
Total Cash (Recent Filing)£40.96M
Total Debt (Recent Filing)£26.91M
Price to Earnings (P/E)22.6
Beta0.75
Next Earnings
Sep 22, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.66%
Share Statistics
EPS (TTM)0.63
Shares Outstanding34,237,150
10 Day Avg. Volume64,377
30 Day Avg. Volume71,707
Financial Highlights & Ratios
PEG Ratio0.76
Price to Book (P/B)3.07
Price to Sales (P/S)5.04
P/FCF Ratio17.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.22
Revenue Forecast (FY)£226.01M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins above 85% indicate durable unit economics from software delivery and low incremental costs. This margin profile supports reinvestment in product, funds long-term R&D, and provides a buffer against pricing pressure in the healthcare IT market.
Conservative Balance SheetVery low leverage gives the company long-term financial flexibility to fund growth, absorb demand cycles, pursue tuck-in M&A, or return capital. A conservative capital structure reduces bankruptcy risk and supports sustained investment in product and services.
Recurring SaaS Revenue ModelA subscription-based model to hospitals delivers predictable, contractually recurring revenue, high retention potential, and easier margin expansion over time via upsells and module sales. This structural revenue base improves cash visibility and long-term planning.
Bears Say
Declining Free Cash Flow GrowthA 13.4% drop in free cash flow growth, if persistent, weakens capacity to fund R&D, acquisitions, or shareholder returns without increasing leverage. Slowing FCF growth can constrain strategic flexibility and raise sensitivity to working-capital or investment cycles.
Modest Net Profitability / Low ROEModest net margins and low ROE suggest the business currently underutilizes shareholder capital relative to peers. Over the medium term this can limit total shareholder returns and indicate room to improve pricing, cost structure, or capital allocation efficiency.
Slow Revenue GrowthMid-single-digit top-line growth implies limited organic expansion versus faster-growing software peers. Slower growth constrains operating leverage and the ability to scale fixed-costs, making margin expansion and market-share gains more challenging over the coming months.
Craneware News
CRW FAQ
What was Craneware Plc’s price range in the past 12 months?
Craneware Plc lowest share price was 1272.34 p and its highest was 2644.00 p in the past 12 months.
What is Craneware Plc’s market cap?
Craneware Plc’s market cap is £478.34M.
When is Craneware Plc’s upcoming earnings report date?
Craneware Plc’s upcoming earnings report date is Sep 22, 2026 which is in 124 days.
How were Craneware Plc’s earnings last quarter?
Craneware Plc released its earnings results on Mar 02, 2026. The company reported 0.422 p earnings per share for the quarter, beating the consensus estimate of N/A by 0.422 p.
Is Craneware Plc overvalued?
According to Wall Street analysts Craneware Plc’s price is currently Overvalued.
Does Craneware Plc pay dividends?
Craneware Plc pays a Semiannually dividend of 18.5 p which represents an annual dividend yield of 1.66%. See more information on Craneware Plc dividends here
What is Craneware Plc’s EPS estimate?
Craneware Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Craneware Plc have?
Craneware Plc has 34,237,150 shares outstanding.
What happened to Craneware Plc’s price movement after its last earnings report?
Craneware Plc reported an EPS of 0.422 p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.99%.
Which hedge fund is a major shareholder of Craneware Plc?
Currently, no hedge funds are holding shares in GB:CRW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Craneware Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.04%
12-Months-Change
Fundamentals
Return on Equity
6.65%
Trailing 12-Months
Asset Growth
-13.53%
Trailing 12-Months
Company Description
Craneware Plc
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits. In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; trisus pricing transparency; InSight Denials to analyze, track, trend, and report on denial data; and appeals services. Further, it offers customer success management and consulting services; professional services; and sales and marketing, and product and software development services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.
Technical Analysis
Options Prices
Currently, No data available
---